Carbocyclic- And Heterocyclic-Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
申请人:PFIZER INC.
公开号:US20160002264A1
公开(公告)日:2016-01-07
The present invention provides compounds of formula I,
wherein the variables R
1
, R
2
, R
5
and b are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
申请人:Pfizer Inc.
公开号:EP2935282A1
公开(公告)日:2015-10-28
US9403846B2
申请人:——
公开号:US9403846B2
公开(公告)日:2016-08-02
[EN] CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS<br/>[FR] COMPOSÉS HEXAHYDROPYRANO[3,4-D][1,3]THIAZIN-2-AMINE SUBSTITUÉS CARBOCYCLIQUES ET HÉTÉROCYCLIQUES
申请人:PFIZER
公开号:WO2014097038A1
公开(公告)日:2014-06-26
The present invention provides compounds of formula (I), wherein the variables R1, R2, R5 and b are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.